This is one of those names that has been left for dead, and was subject to a sharp sell-off early in the trading session today. It is probably safe to attribute the severe drawdown to a popular research service and long-time backer of the company finally capitulating.

Sure enough, the shares are already up significantly from the intra-day low, and closed down only 3.57%. I blinked and missed it, but perhaps that is the capitulatory bottom that was needed for an attractive looking trade, especially with profitability metrics inflecting (EBITDA positivity only, but still), and the business looking to be up for sale too with the recent Strategic Review.